BioCentury
ARTICLE | Clinical News

Androgel-DHT dihydrotestosterone topical gel: UMED began a Phase II trial in 20 AIDS patients.

April 8, 1996 7:00 AM UTC

Unimed Pharmaceuticals Inc. (UMED), Buffalo Grove, Ill. Product: Androgel-DHT dihydrotestosterone topical gel Indication: HIV wasting syndrome and low testosterone (hypogonadism) in AIDS Status: UMED...